Skip to content

Feasibility study of mindful music therapy on anxiety in patients with polycystic ovary syndrome: a randomized controlled trial

Feasibility study of mindful music therapy on anxiety in patients with polycystic ovary syndrome: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066322
Enrollment
Unknown
Registered
2022-12-01
Start date
2022-12-02
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome

Interventions

Intervention group:Mindfulness music
Control group:Routine care

Sponsors

North China University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 49 Years

Inclusion criteria

Inclusion criteria: (1) According to the diagnostic criteria of PCOS proposed by the European Society of Reproductive and Embryology (ESHRE) and the American Society of Reproductive Medicine (ASRM) at the Rotterdam meeting in 2003 [84], ? sparse ovulation or anovulation; ? Ultrasound showed that there were more than 12 small follicles with a diameter of 2-9mm in unilateral or bilateral ovaries, or/and ovarian volume =10cm3. ? Clinical or laboratory tests suggest hyperandrogenemia (except for tumors or diseases that pathologically cause hyperandrogenemia). PCOS can be diagnosed by meeting two criteria. (2) They had mild to moderate anxiety, and the total score of anxiety state-trait scale was greater than or equal to 20, and less than 60. (3) Unconscious barriers can be communicated. (4) Aged 18-49. (5) Patients gave informed consent to the study and signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with intellectual disabilities or mental diseases. (2) Patients with severe visual and hearing loss. (3) Patients with drug abuse and alcohol dependence. (4) Patients suspected of Cushing syndrome. (5) Patients suspected of cervical cancer. (6) Congenital adrenal hyperplasia, androgen-releasing tumor and other diseases that cause androgen increase. (7) Severe heart, liver and renal insufficiency, or other serious physical diseases.

Design outcomes

Primary

MeasureTime frame
anxiety;

Secondary

MeasureTime frame
sleep quality;Quality of life;Depression;Body mass index;

Countries

China

Contacts

Public ContactWang Wenqing

North China University of Science and Technology

wangwenqing1996@126.com18253712237

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026